+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Severe hyponatremia: a comorbidity with I131 therapy in a patient with papillary thyroid cancer

Severe hyponatremia: a comorbidity with I131 therapy in a patient with papillary thyroid cancer

Journal of the Medical Association of Thailand 97(8): 886-890

Hyponatremia is the most common electrolyte disorder in hospitalized patients, especially in elderly patients, in which morbidity varies widely in severity. A 64-year-old Thai woman with papillary thyroid cancer who developed hypothyroid state after thyroid hormone withdrawal for preparation of 1-131 treatment, had severe hyponatremia within the day of 1-131 administration. It is possible that the combination of old age, hypothyroidism, severe nausea and vomiting, and inappropriate secretion of antidiuretic hormone (SIADH) may all have precipitated the severe hyponatremia in the presented case.

(PDF emailed within 1 workday: $29.90)

Accession: 055739672

Download citation: RISBibTeXText

PMID: 25345266

Related references

Severe hyponatremia in association with I(131) therapy in a patient with metastatic thyroid cancer. Internal Medicine 50(19): 2169-2174, 2012

Upper neck papillary thyroid cancer (UPTC): A new proposed term for the composite of thyroglossal duct cyst-associated papillary thyroid cancer, pyramidal lobe papillary thyroid cancer, and Delphian node papillary thyroid cancer metastasis. Laryngoscope 126(7): 1709-1714, 2015

Hyponatremia after thyroid hormone withdrawal in a patient with papillary thyroid carcinoma. Endocrinology and Metabolism 29(1): 77-82, 2014

Severe hyponatremia following radioactive iodine therapy in patients with differentiated thyroid cancer. Thyroid 24(4): 773-777, 2015

Severe hyponatremia in postoperatory of papillary thyroid carcinoma as a manifestation of acute intermittent porphyria. Medicina Clinica 136(12): 556-557, 2011

SPECT/CT and I131 therapy of brain metastases from follicular variant papillary thyroid carcinoma (FVPTC). Journal of Clinical Endocrinology and Metabolism 99(10): 3511-3512, 2015

Efficacy of I131 ablation therapy using different doses as determined by postoperative thyroid scan uptake in patients with differentiated thyroid cancer. International Journal of Radiation Oncology, Biology, Physics 59(5): 1330-1336, 2004

Serum I131 fractionation in metastatic carcinoma of the thyroid; the fate of endogenous radiothyroxine after I131 therapy. Cancer 8(6): 1115-1121, 1955

Co-occurrence of papillary thyroid cancer and MALT lymphoma of the thyroid with severe airway obstruction: A case report and review of the literature. International Journal of Surgery Case Reports 5(9): 594-597, 2014

Symptomatic hyponatremia in association with a low-iodine diet and levothyroxine withdrawal prior to I131 in patients with metastatic thyroid carcinoma. Thyroid 18(7): 787-792, 2008

Rhabdomyolysis after withdrawal of thyroid hormone in a patient with papillary thyroid cancer. Endocrine Practice 14(8): 1023-1026, 2009

Indoleamine 2,3-Dioxygenase Activity during I131-Radioisotope Therapy for Metastatic Thyroid Cancer. Gan to Kagaku Ryoho. Cancer & ChemoTherapy 42(10): 1259-1261, 2016

Clinical outcome, role of BRAF(V600E), and molecular pathways in papillary thyroid microcarcinoma: is it an indolent cancer or an early stage of papillary thyroid cancer?. Frontiers in Endocrinology 3: 33-33, 2012

F-18 FDG-PET-CT in the Diagnostic of a Late Medullary Thyroid Carcinoma Recurrence in a Patient with Follicular-Papillary Thyroid Cancer. Case Reports in Endocrinology 2014: 741262-741262, 2014

Papillary thyroid carcinoma in a patient with severe psoriasis receiving adalimumab. Journal of the American Academy of Dermatology 64(5): 999-1000, 2011